Colorectal cancer liver metastases and concurrent extrahepatic disease treated with resection

Annals of Surgery

Volumn 265, Issue 1, 2017, Pages 158-165

  Leung, Universe ^a   Gönen, Mithat ^a   Allen, Peter J ^a   Kingham, T Peter ^a   DeMatteo, Ronald P ^a   Jarnagin, William R ^a   D'Angelica, Michael I ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Colorectal cancer; Extrahepatic metastases; Liver metastases; Liver resection

Indexed keywords

BEVACIZUMAB; CETUXIMAB; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; COLORECTAL CANCER; EXTRAHEPATIC DISEASE; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LIVER DISEASE; LIVER METASTASIS; LIVER RESECTION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL RATE; ADRENAL TUMOR; COLORECTAL TUMOR; LIVER NEOPLASMS; LUNG TUMOR; LYMPH NODE METASTASIS; MORTALITY; MULTIVARIATE ANALYSIS; OVARY TUMOR; PATHOLOGY; PERITONEUM TUMOR; PROGNOSIS; SECONDARY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84954357533     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001624     Document Type: Article

References (21)

1. Ito K, Govindarajan A, Ito H, et al. Surgical treatment of hepatic colorectal metastasis: Evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century. Cancer J. 2010; 16: 103-110.
2. Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007; 25: 4575-4580.
3. Nikfarjam M, Shereef S, Kimchi ET, et al. Survival outcomes of patients with colorectal liver metastases following hepatic resection or ablation in the era of effective chemotherapy. Ann Surg Oncol. 2009; 16: 1860-1867.
4. House MG, Ito H, Gonen M, et al. Survival after hepatic resection for metastatic colorectal cancer: Trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg. 2010; 210: 744-752. 752-745.
5. Pulitano C, Castillo F, Aldrighetti L, et al. What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford). 2010; 12: 244-249.
6. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg. 1999; 230: 309-318 [discussion 318-321].
7. Elias D, Ouellet JF, Bellon N, et al. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg. 2003; 90: 567-574.
8. Aoki T, Umekita N, Tanaka S, et al. Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin. Surgery. 2008; 143: 706-714.
9. Carpizo DR, D'Angelica M. Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. Lancet Oncol. 2009; 10: 801-809.
10. Adam R, de Haas RJ,Wicherts DA, et al. Concomitant extrahepatic disease in patients with colorectal liver metastases: When is there a place for surgery? Ann Surg. 2011; 253: 349-359.
11. Pulitano C, Bodingbauer M, Aldrighetti L, et al. Liver resection for colorectal metastases in presence of extrahepatic disease: Results from an international multi-institutional analysis. Ann Surg Oncol. 2011; 18: 1380-1388.
12. Pulitano C, Bodingbauer M, Aldrighetti L, et al. Colorectal liver metastasis in the setting of lymph node metastasis: Defining the benefit of surgical resection. Ann Surg Oncol. 2012; 19: 435-442.
13. Elias D, Liberale G, Vernerey D, et al. Hepatic and extrahepatic colorectal metastases: When resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol. 2005; 12: 900-909.
14. Adam R, de Haas RJ, Wicherts DA, et al. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol. 2008; 26: 3672-3680.
15. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinomametastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 1996; 77: 1254-1262.
16. Iwatsuki S, Dvorchik I, Madariaga JR, et al. Hepatic resection for metastatic colorectal adenocarcinoma: A proposal of a prognostic scoring system. J Am Coll Surg. 1999; 189: 291-299.
17. Nagashima I, Takada T, Adachi M, et al. Proposal of criteria to select candidates with colorectal liver metastases for hepatic resection: Comparison of our scoring system to the positive number of risk factors. World J Gastroenterol. 2006; 12: 6305-6309.
18. Konopke R, Kersting S, Distler M, et al. Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int. 2009; 29: 89-102.
19. Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol. 2004; 22: 229-237.
20. Moulton CA, Gu CS, Law CH, et al. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: A randomized clinical trial. JAMA. 2014; 311: 1863-1869.
21. Zakaria S, Donohue JH, Que FG, et al. Hepatic resection for colorectal metastases: Value for risk scoring systems? Ann Surg. 2007; 246: 183-191.